NTRK2 and obesity disorder: We found that re-expressing Bdnf-e2 transcript or injection of a TrkB agonistic antibody in a hypothalamic nucleus could reverse the hyperphagia and obesity phenotypes in Bdnf-e2−/− mice to the levels of wild-type (WT) mice.